Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

References for PMC Articles for PubMed (Select 21642621)

1.

Pathological signaling via platelet-derived growth factor receptor {alpha} involves chronic activation of Akt and suppression of p53.

Lei H, Velez G, Kazlauskas A.

Mol Cell Biol. 2011 May;31(9):1788-99. doi: 10.1128/MCB.01321-10. Epub 2011 Feb 28.

2.

Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery.

Sundaram V, Barsam A, Virgili G.

Cochrane Database Syst Rev. 2010 Jul 7;(7):CD006421. doi: 10.1002/14651858.CD006421.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD006421.

PMID:
20614445
3.

N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy.

Lei H, Velez G, Cui J, Samad A, Maberley D, Matsubara J, Kazlauskas A.

Am J Pathol. 2010 Jul;177(1):132-40. doi: 10.2353/ajpath.2010.090604. Epub 2010 May 20.

4.

Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy.

Lei H, Rheaume MA, Kazlauskas A.

Exp Eye Res. 2010 Mar;90(3):376-81. doi: 10.1016/j.exer.2009.11.003. Epub 2009 Nov 25. Review.

5.

Growth factors outside the PDGF family drive experimental PVR.

Lei H, Velez G, Hovland P, Hirose T, Gilbertson D, Kazlauskas A.

Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3394-403. doi: 10.1167/iovs.08-3042. Epub 2009 Mar 25.

7.

PDGF receptors are activated in human epiretinal membranes.

Cui J, Lei H, Samad A, Basavanthappa S, Maberley D, Matsubara J, Kazlauskas A.

Exp Eye Res. 2009 Mar;88(3):438-44. doi: 10.1016/j.exer.2008.10.020. Epub 2008 Nov 8.

8.

A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy.

Lei H, Hovland P, Velez G, Haran A, Gilbertson D, Hirose T, Kazlauskas A.

Invest Ophthalmol Vis Sci. 2007 May;48(5):2335-42.

PMID:
17460299
9.

In vivo models of proliferative vitreoretinopathy.

Agrawal RN, He S, Spee C, Cui JZ, Ryan SJ, Hinton DR.

Nat Protoc. 2007;2(1):67-77.

PMID:
17401340
10.

Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy.

Cui JZ, Chiu A, Maberley D, Ma P, Samad A, Matsubara JA.

Eye (Lond). 2007 Feb;21(2):200-8. Epub 2006 Mar 10.

PMID:
16531976
11.

Platelet-derived growth factor receptor kinase inhibitor AG1295 and inhibition of experimental proliferative vitreoretinopathy.

Zheng Y, Ikuno Y, Ohj M, Kusaka S, Jiang R, Cekiç O, Sawa M, Tano Y.

Jpn J Ophthalmol. 2003 Mar-Apr;47(2):158-65.

PMID:
12738549
12.

Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells.

Wong CA, Potter MJ, Cui JZ, Chang TS, Ma P, Maberley AL, Ross WH, White VA, Samad A, Jia W, Hornan D, Matsubara JA.

Can J Ophthalmol. 2002 Jun;37(4):211-20.

PMID:
12095094
13.
14.

TGFbeta1-dependent contraction of fibroblasts is mediated by the PDGFalpha receptor.

Ikuno Y, Kazlauskas A.

Invest Ophthalmol Vis Sci. 2002 Jan;43(1):41-6.

PMID:
11773010
15.

Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor.

Ikuno Y, Leong FL, Kazlauskas A.

Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3107-16.

PMID:
10967071
16.

Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy.

Andrews A, Balciunaite E, Leong FL, Tallquist M, Soriano P, Refojo M, Kazlauskas A.

Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2683-9.

PMID:
10509666
17.

Growth factors in proliferative vitreoretinopathy.

Charteris DG.

Br J Ophthalmol. 1998 Feb;82(2):106. No abstract available.

18.

Pathogenic mechanisms in proliferative vitreoretinopathy.

Campochiaro PA.

Arch Ophthalmol. 1997 Feb;115(2):237-41. Review.

PMID:
9046259
19.

Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy.

Baudouin C, Fredj-Reygrobellet D, Brignole F, Nègre F, Lapalus P, Gastaud P.

Ophthalmic Res. 1993;25(1):52-9.

PMID:
8446368
20.

Traction retinal detachment. XLIX Edward Jackson Memorial Lecture.

Ryan SJ.

Am J Ophthalmol. 1993 Jan;115(1):1-20. Review.

PMID:
8420359
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk